P0DTU4 (TRBR2_HUMAN) Homo sapiens (Human)
T cell receptor beta chain MC.7.G5 UniProtKBInterProInteractive Modelling
315 aa; Sequence (Fasta)
Available Structures
12 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
TCR - CD3 complex bound to HLA |
Heteromer H9BNV4; P01848; P04234; P07766; P09693; P20963; P61769; P78358; | 50.0 | 1×NAG; 8×NAG; 2×CLR; | |||
N17.1.2 recognition of NRAS neoantigens |
Heteromer F6IQR9; P01116; P01848; P61769; | 52.58 | 8×GOL; 2×EDO; | |||
N17.1.2 recognition of NRAS neoantigens |
Heteromer P01848; | 52.08 | ||||
N17.1.2 recognition of NRAS neoantigens |
Heteromer F6IQR9; P01116; P01848; P61769; | 51.58 | ||||
Structure of MC.7.G5 T cell receptor in complex with MR1 R9H |
Heteromer P0DTU3; P61769; Q95460; | 98.78 | ||||
Crystal structure of ternary complex of human MR1, ligand #4, and MAIT-TCR A-F7 |
Heteromer P01848; P61769; Q95460; | 50.0 | 1×A1LXU; | |||
TCR in nanodisc ND-I |
Heteromer A0A0K0K1A5; P01848; P04234; P07766; P09693; P20963; | 100.0 | 2×NAG; 1×NAG; 3×NAG; 2×CLR; | |||
TCR in nanodisc ND-II |
Heteromer A0A0K0K1A5; P04234; P07766; P09693; P20963; | 100.0 | 1×NAG; 2×CLR; 1×NAG; | |||
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 index peptide |
Heteromer A0A075B6T6; A0A0K0K1A5; P0DTU3; P13747; P61769; Q67953; | 25.0 | ||||
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 S3N peptide |
Heteromer A0A075B6T6; A0A0K0K1A5; P0DTU3; P13747; P61769; Q67953; | 25.0 | ||||
TCR in complex with HLA-E*01:03 bound to HBV envelope 371-379 L6I peptide |
Heteromer A0A075B6T6; A0A0K0K1A5; P0DTU3; P13747; P61769; Q67953; | 25.0 | ||||
T-cell receptor and lipid complex structure |
Heteromer A0A0B4J1J9; A2NTY6; K7N5M3; P01887; P11609; | 100 | 2×NAG; 1×NAG; 1×Y73; | |||
2 SWISS-MODEL models
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
8es7.1.H | monomer | 0.79 | 77.56 | |||
8tw4.1.B | monomer | 0.59 | 79.03 | |||